Rocket One (RKTO) Non-Current Assets (2017 - 2026)
Rocket One's (RKTO) quarterly Non-Current Assets came in at $1.0 million in Q2 2026, up 1728.7% year-over-year from $54900.0 in Q2 2025, and up 36.36% quarter-over-quarter from $736239.0 in Q1 2026.
Analysis
Rocket One (RKTO) Non-Current Assets (2017 - 2026) Analysis & Trends
Rocket One has disclosed Non-Current Assets across 10 years of filings, most recently posting $1.0 million for Q2 2026.
- In Q2 2026, Non-Current Assets rose 1728.7% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (up 1728.7% YoY), while the FY2025 annual figure was $740891.0, up 991.25% from the prior year.
- Non-Current Assets came in at $1.0 million for Q2 2026 at Rocket One, up from $736239.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.0 million in Q2 2026 to a low of $33000.0 in Q4 2022.
- Average Non-Current Assets over 5 years is $257285.5, with a median of $81482.0 recorded in 2024.
- Year-over-year, Non-Current Assets plunged 91.95% in 2022 and jumped 1728.7% in 2026.
- Over 5 years, Non-Current Assets stood at $33000.0 in 2022, then jumped by 180.5% to $92565.0 in 2023, then fell by 26.65% to $67894.0 in 2024, then soared by 991.25% to $740891.0 in 2025, then jumped by 35.51% to $1.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $1.0 million in Q2 2026, $736239.0 in Q1 2026, and $740891.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 564.41 Mn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 736,239.00 |
| Dec 31, 2025 | 740,891.00 |
| Sep 30, 2025 | 322,978.00 |
| Jun 30, 2025 | 54,900.00 |
| Mar 31, 2025 | 61,328.00 |
| Dec 31, 2024 | 67,894.00 |
| Sep 30, 2024 | 70,626.00 |
| Jun 30, 2024 | 77,923.00 |
| Mar 31, 2024 | 85,041.00 |
| Dec 31, 2023 | 92,565.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 387,400.00 |
| Jun 30, 2022 | 387,400.00 |
| Mar 31, 2022 | 410,000.00 |
| Dec 31, 2021 | 410,000.00 |
| Sep 30, 2021 | 410,000.00 |